Treatment Trials

2 Clinical Trials for Various Conditions

Focus your search

      COMPLETED
      A Safety and Efficacy Study of 552-02 in Subjects With Dry Mouth Associated With Sjogren's Syndrome
      Description

      This clinical study is to determine whether daily administration of a formulation of 552-02 improves the dry mouth condition in subjects with primary Sjögren's syndrome.

      Conditions
      Dry Mouth Associated With Sjogren's SyndromeXerostomia
      Talk to us
      COMPLETED
      Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome
      Description

      The purpose of this study is to evaluate the effectiveness of NGX267 in the improvement of decreased salivary flow associated with primary or secondary Sjögren's syndrome. For each patient, the study includes four periods of treatment separated by a washout period that may range from 4 - 8 days according to patient and site discretion. Each treatment period includes two overnight stays in the clinic. One dose of study drug is taken during each treatment period

      Conditions
      XerostomiaSjogren's Syndrome
      Talk to us